<!DOCTYPE html>
<html lang="en">
<head>
  <!-- Google tag (gtag.js) -->
  <script async src="https://www.googletagmanager.com/gtag/js?id=G-LSRR4KW715"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);}
    gtag('js', new Date());

    gtag('config', 'G-LSRR4KW715');
  </script>


  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Case 21.3 - Coeliac [SDL]</title>

  <!-- Favicon -->
  <link rel="icon" type="image/png" href="../assets/ShepTech logo.png">
  <link rel="apple-touch-icon" href="../assets/ShepTech logo.png">

  <!-- Primary Meta Tags -->
  <meta name="title" content="Case 21.3 - Coeliac [SDL] | MD3 SCP Cases">
  <meta name="description" content="Medical case study for MD3 students.">

  <!-- Open Graph / Facebook -->
  <meta property="fb:app_id" content="your_facebook_app_id">
  <meta property="og:type" content="article">
  <meta property="og:title" content="Case 21.3 - Coeliac [SDL]">
  <meta property="og:site_name" content="MD3 SCP Cases">
  <meta property="og:description" content="Medical case study for MD3 students.">
  <meta property="og:image" content="https://md3-scp.netlify.app/assets/ShepTech%20logo.png">
  <link rel="stylesheet" href="../css/case.css">

  <!-- Firebase SDK -->
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-app-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-auth-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-firestore-compat.js"></script>
</head>
<body>
  <div class="container">
    <div class="case-header">
      <a href="#" class="back-link" onclick="goBack(event)">← Back to Cases</a>
    </div>

    <h1>Case 21.3 – Coeliac Disease [SDL]</h1>
    <p class="meta"><strong>Category:</strong> Medicine | <strong>Discipline:</strong> Gastroenterology | <strong>Setting:</strong> GP Practice</p>

    <h2>Case</h2>
    <p>Ms. Sarah Mitchell, a 28-year-old primary school teacher, presents to her GP with a 6-month history of intermittent diarrhoea, bloating, and abdominal discomfort. She describes 3-4 loose, pale, "frothy" stools per day that are difficult to flush. She has also noticed increased flatulence and feels "constantly bloated". She has lost 5 kg despite having a good appetite. She reports feeling increasingly fatigued and has noticed she bruises more easily than usual. She mentions that her younger brother was recently diagnosed with type 1 diabetes. On examination, she appears pale and thin (BMI 18). She has angular stomatitis and some small bruises on her arms. Abdominal examination reveals mild distension but is otherwise unremarkable.</p>

    <div class="vital-signs">Vital signs: BP 115/75 mmHg, HR 88 bpm, Temp 36.7°C. Pale conjunctivae, angular stomatitis noted</div>

    <h2>Self-Directed Learning Tasks</h2>
    <p><strong>This is a Self-Directed Learning (SDL) case. Use the questions below to guide your independent study of coeliac disease.</strong></p>

    <h2>Questions</h2>

    <div class="question">
      <strong>1. What is coeliac disease, and what is its pathophysiology?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Definition:</strong></p>
        <p>Coeliac disease is a chronic immune-mediated enteropathy triggered by exposure to dietary gluten in genetically predisposed individuals. It affects approximately 1% of the population in Western countries, though many cases remain undiagnosed.</p>
        <p><strong>Pathophysiology:</strong></p>
        <ul>
          <li><strong>Trigger:</strong> Gluten proteins (gliadin from wheat, hordein from barley, secalin from rye)
            <ul>
              <li>Gluten peptides are resistant to complete digestion by gastric and pancreatic enzymes</li>
              <li>Incompletely digested gluten peptides reach the small intestine</li>
            </ul>
          </li>
          <li><strong>Immune response in genetically susceptible individuals:</strong>
            <ul>
              <li><strong>Innate immune response:</strong> Gluten peptides cause direct epithelial damage</li>
              <li><strong>Adaptive immune response:</strong>
                <ul>
                  <li>Tissue transglutaminase (tTG) deamidates gluten peptides, increasing their immunogenicity</li>
                  <li>Modified gluten peptides are presented by antigen-presenting cells to T cells</li>
                  <li>T cell activation leads to inflammatory cascade</li>
                  <li>Production of antibodies against:
                    <ul>
                      <li>Tissue transglutaminase (anti-tTG)</li>
                      <li>Endomysium (anti-EMA)</li>
                      <li>Deamidated gliadin peptides (anti-DGP)</li>
                    </ul>
                  </li>
                </ul>
              </li>
            </ul>
          </li>
          <li><strong>Tissue damage:</strong>
            <ul>
              <li>Chronic inflammation of small intestinal mucosa</li>
              <li>Villous atrophy (flattening of intestinal villi)</li>
              <li>Crypt hyperplasia</li>
              <li>Increased intraepithelial lymphocytes</li>
              <li>Results in reduced absorptive surface area → malabsorption</li>
            </ul>
          </li>
        </ul>
        <p><strong>Genetic Factors:</strong></p>
        <ul>
          <li>Strong genetic component:
            <ul>
              <li>95% of patients are HLA-DQ2 positive</li>
              <li>Most others are HLA-DQ8 positive</li>
              <li>However, ~30% of general population carry these genes but only ~1% develop coeliac disease</li>
              <li>Other genetic and environmental factors contribute</li>
            </ul>
          </li>
          <li>First-degree relatives have 10% risk (compared to 1% in general population)</li>
          <li>Concordance in identical twins: ~75%</li>
        </ul>
        <p><strong>Environmental Factors:</strong></p>
        <ul>
          <li>Timing and amount of gluten introduction in infancy</li>
          <li>Gastrointestinal infections</li>
          <li>Gut microbiome composition</li>
        </ul>
      </div>
    </div>

    <div class="question">
      <strong>2. What are the clinical presentations of coeliac disease? How might it present differently in children versus adults?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Classical GI Presentation (more common in children):</strong></p>
        <ul>
          <li>Chronic diarrhoea (often steatorrhoea - pale, floating, offensive stools)</li>
          <li>Abdominal pain and bloating</li>
          <li>Excessive flatulence</li>
          <li>Weight loss or failure to thrive (children)</li>
          <li>Nausea and vomiting</li>
        </ul>
        <p><strong>Non-Classical Presentations (increasingly recognized, especially in adults):</strong></p>
        <p><strong>Nutritional deficiencies due to malabsorption:</strong></p>
        <ul>
          <li><strong>Iron deficiency anaemia:</strong> Most common presentation in adults
            <ul>
              <li>Often refractory to oral iron</li>
              <li>Due to malabsorption in proximal small bowel</li>
            </ul>
          </li>
          <li><strong>Folate and B12 deficiency:</strong> Macrocytic anaemia</li>
          <li><strong>Vitamin D and calcium deficiency:</strong>
            <ul>
              <li>Osteoporosis or osteomalacia</li>
              <li>Increased fracture risk</li>
              <li>Bone pain</li>
            </ul>
          </li>
          <li><strong>Vitamin K deficiency:</strong> Easy bruising, bleeding tendency</li>
          <li><strong>Fat-soluble vitamin deficiencies:</strong> Vitamins A, D, E, K</li>
          <li><strong>Protein malnutrition:</strong> Hypoalbuminaemia, peripheral oedema</li>
        </ul>
        <p><strong>Dermatological:</strong></p>
        <ul>
          <li><strong>Dermatitis herpetiformis:</strong>
            <ul>
              <li>Intensely itchy, blistering rash</li>
              <li>Typically on extensor surfaces (elbows, knees, buttocks, scalp)</li>
              <li>Pathognomonic for coeliac disease</li>
              <li>IgA deposits in dermal papillae on skin biopsy</li>
            </ul>
          </li>
          <li>Angular stomatitis</li>
          <li>Atrophic glossitis</li>
          <li>Aphthous ulcers</li>
        </ul>
        <p><strong>Reproductive:</strong></p>
        <ul>
          <li>Delayed puberty</li>
          <li>Amenorrhoea or irregular periods</li>
          <li>Infertility (both male and female)</li>
          <li>Recurrent miscarriages</li>
        </ul>
        <p><strong>Neurological:</strong></p>
        <ul>
          <li>Peripheral neuropathy</li>
          <li>Ataxia (gluten ataxia)</li>
          <li>Epilepsy</li>
          <li>Cognitive impairment, "brain fog"</li>
          <li>Headaches</li>
        </ul>
        <p><strong>Hepatic:</strong></p>
        <ul>
          <li>Abnormal liver function tests (often mild transaminitis)</li>
          <li>Usually normalizes with gluten-free diet</li>
        </ul>
        <p><strong>Other:</strong></p>
        <ul>
          <li>Dental enamel hypoplasia</li>
          <li>Short stature in children</li>
          <li>Chronic fatigue</li>
          <li>Depression and anxiety</li>
        </ul>
        <p><strong>Asymptomatic/Silent Coeliac Disease:</strong></p>
        <ul>
          <li>Positive serology and villous atrophy on biopsy</li>
          <li>No obvious symptoms</li>
          <li>May be detected through screening of at-risk groups</li>
        </ul>
        <p><strong>Differences Between Children and Adults:</strong></p>
        <p><strong>Children:</strong></p>
        <ul>
          <li>More likely to present with classical GI symptoms</li>
          <li>Failure to thrive, growth retardation</li>
          <li>Irritability and behavioural changes</li>
          <li>Abdominal distension with muscle wasting ("pot belly" appearance)</li>
          <li>Delayed puberty</li>
          <li>Dental enamel defects</li>
        </ul>
        <p><strong>Adults:</strong></p>
        <ul>
          <li>More likely to have non-classical presentations</li>
          <li>Iron deficiency anaemia most common presentation</li>
          <li>Osteoporosis</li>
          <li>Subtle or absent GI symptoms in up to 50%</li>
          <li>May present with extraintestinal manifestations only</li>
          <li>Diagnosis often delayed due to varied presentation</li>
        </ul>
      </div>
    </div>

    <div class="question">
      <strong>3. Which patient groups should be screened for coeliac disease, and what investigations should be performed?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>High-Risk Groups Warranting Screening:</strong></p>
        <p><strong>Strong indications for testing:</strong></p>
        <ul>
          <li><strong>First-degree relatives of coeliac patients:</strong> 10% risk</li>
          <li><strong>Autoimmune conditions:</strong>
            <ul>
              <li>Type 1 diabetes mellitus (5-10% prevalence)</li>
              <li>Autoimmune thyroid disease</li>
              <li>Autoimmune hepatitis</li>
              <li>Primary biliary cholangitis</li>
              <li>Addison's disease</li>
              <li>Sjögren's syndrome</li>
            </ul>
          </li>
          <li><strong>Genetic syndromes:</strong>
            <ul>
              <li>Down syndrome (5-12% prevalence)</li>
              <li>Turner syndrome</li>
              <li>Williams syndrome</li>
            </ul>
          </li>
          <li><strong>IgA deficiency:</strong> 10-fold increased risk
            <ul>
              <li>Important as standard serological tests (IgA-based) will be falsely negative</li>
            </ul>
          </li>
        </ul>
        <p><strong>Clinical presentations requiring testing:</strong></p>
        <ul>
          <li>Chronic or intermittent diarrhoea</li>
          <li>Unexplained iron deficiency anaemia</li>
          <li>Unexplained weight loss</li>
          <li>Persistent or unexplained GI symptoms</li>
          <li>Dermatitis herpetiformis</li>
          <li>Unexplained abnormal liver function tests</li>
          <li>Metabolic bone disease (osteoporosis in young patients)</li>
          <li>Unexplained neurological symptoms (ataxia, peripheral neuropathy)</li>
          <li>Infertility or recurrent miscarriage</li>
          <li>Dental enamel defects</li>
          <li>Chronic fatigue</li>
        </ul>
        <p><strong>Investigations:</strong></p>
        <p><strong>IMPORTANT: Patients must be on a gluten-containing diet for accurate testing</strong></p>
        <ul>
          <li>Should consume gluten in at least one meal daily for minimum 6 weeks before testing</li>
          <li>Starting gluten-free diet before testing can lead to false negative results</li>
        </ul>
        <p><strong>First-line Serological Tests:</strong></p>
        <ul>
          <li><strong>Tissue transglutaminase IgA (tTG-IgA):</strong>
            <ul>
              <li>Test of choice, highest sensitivity and specificity (~95%)</li>
              <li>Most cost-effective</li>
            </ul>
          </li>
          <li><strong>Total IgA level:</strong>
            <ul>
              <li>Must be checked simultaneously with tTG-IgA</li>
              <li>To detect IgA deficiency (which would make tTG-IgA falsely negative)</li>
              <li>If IgA deficient: use IgG-based tests instead</li>
            </ul>
          </li>
        </ul>
        <p><strong>Additional/Alternative Serological Tests:</strong></p>
        <ul>
          <li><strong>Endomysial antibody IgA (EMA-IgA):</strong>
            <ul>
              <li>Very high specificity (~100%)</li>
              <li>Used as confirmatory test</li>
              <li>More expensive and operator-dependent</li>
            </ul>
          </li>
          <li><strong>Deamidated gliadin peptide (DGP) antibodies (IgA and IgG):</strong>
            <ul>
              <li>Less sensitive than tTG</li>
              <li>May be useful in children <2 years</li>
              <li>IgG-DGP used in IgA-deficient patients</li>
            </ul>
          </li>
          <li><strong>tTG-IgG:</strong> For IgA-deficient patients</li>
        </ul>
        <p><strong>Definitive Diagnosis - Small Bowel Biopsy:</strong></p>
        <ul>
          <li><strong>Upper GI endoscopy (OGD) with duodenal biopsies:</strong>
            <ul>
              <li>Gold standard for diagnosis in adults</li>
              <li>Multiple biopsies required (≥4-6 from second part of duodenum)</li>
              <li>Patchy disease → need multiple samples</li>
            </ul>
          </li>
          <li><strong>Histological features (Marsh classification):</strong>
            <ul>
              <li>Increased intraepithelial lymphocytes (Marsh 1)</li>
              <li>Crypt hyperplasia (Marsh 2)</li>
              <li>Villous atrophy:
                <ul>
                  <li>Partial (Marsh 3a)</li>
                  <li>Subtotal (Marsh 3b)</li>
                  <li>Total (Marsh 3c)</li>
                </ul>
              </li>
            </ul>
          </li>
          <li><strong>Biopsy essential because:</strong>
            <ul>
              <li>Confirms diagnosis before committing to lifelong gluten-free diet</li>
              <li>Other conditions can cause positive serology</li>
              <li>Establishes baseline for monitoring</li>
            </ul>
          </li>
        </ul>
        <p><strong>Exception in Children:</strong></p>
        <ul>
          <li>ESPGHAN criteria allow diagnosis without biopsy in selected cases:
            <ul>
              <li>Symptomatic children</li>
              <li>tTG-IgA >10x upper limit of normal</li>
              <li>Positive EMA in separate blood sample</li>
              <li>HLA-DQ2 or DQ8 positive</li>
            </ul>
          </li>
        </ul>
        <p><strong>Genetic Testing (HLA-DQ2/DQ8):</strong></p>
        <ul>
          <li>NOT used for diagnosis (too many false positives in general population)</li>
          <li>Useful for:
            <ul>
              <li>Ruling out coeliac disease (negative predictive value >99%)</li>
              <li>Patients already on gluten-free diet who can't/won't do gluten challenge</li>
              <li>Uncertain cases</li>
              <li>Screening high-risk individuals</li>
            </ul>
          </li>
        </ul>
        <p><strong>Other Investigations to Assess Complications:</strong></p>
        <ul>
          <li>Full blood count (anaemia)</li>
          <li>Iron studies, B12, folate</li>
          <li>Liver function tests</li>
          <li>Calcium, vitamin D, PTH</li>
          <li>Bone density scan (DEXA) if risk factors for osteoporosis</li>
          <li>Thyroid function (associated autoimmune thyroid disease)</li>
        </ul>
        <p><strong>Diagnostic Algorithm:</strong></p>
        <ol>
          <li>Ensure patient is on gluten-containing diet</li>
          <li>Check tTG-IgA + total IgA</li>
          <li>If tTG-IgA positive: refer for endoscopy with duodenal biopsies</li>
          <li>If total IgA low: use IgG-based tests</li>
          <li>Diagnosis requires positive serology + characteristic histology (except selected paediatric cases)</li>
        </ol>
      </div>
    </div>

    <div class="question">
      <strong>4. What is the management of coeliac disease, and what are the potential complications of untreated disease?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Management of Coeliac Disease:</strong></p>
        <p><strong>1. Lifelong Strict Gluten-Free Diet (GFD):</strong></p>
        <ul>
          <li><strong>Cornerstone of treatment - only effective therapy</strong></li>
          <li><strong>Complete avoidance of:</strong>
            <ul>
              <li>Wheat, barley, rye, and their derivatives</li>
              <li>Oats are controversial:
                <ul>
                  <li>Pure, uncontaminated oats may be tolerated by most</li>
                  <li>Some patients react to avenin (oat protein)</li>
                  <li>Introduce cautiously under supervision</li>
                </ul>
              </li>
            </ul>
          </li>
          <li><strong>Hidden sources of gluten:</strong>
            <ul>
              <li>Processed foods, sauces, medications, supplements</li>
              <li>Cross-contamination during food preparation</li>
              <li>Need careful label reading</li>
            </ul>
          </li>
          <li><strong>Safe alternatives:</strong>
            <ul>
              <li>Rice, corn, quinoa, buckwheat, millet, sorghum</li>
              <li>Potatoes, legumes</li>
              <li>Naturally gluten-free foods (meat, fish, eggs, dairy, fruits, vegetables)</li>
            </ul>
          </li>
          <li><strong>Expected response to GFD:</strong>
            <ul>
              <li>Symptom improvement within weeks</li>
              <li>Antibody levels normalize within 6-12 months</li>
              <li>Histological recovery may take 2 years or longer</li>
              <li>Some patients (particularly adults) may have incomplete villous recovery</li>
            </ul>
          </li>
        </ul>
        <p><strong>2. Dietitian Support:</strong></p>
        <ul>
          <li>Specialist coeliac dietitian essential</li>
          <li>Education about gluten-free diet</li>
          <li>Nutritional assessment and advice</li>
          <li>Ensure adequate intake of fibre, vitamins, minerals</li>
          <li>Help with meal planning and food label reading</li>
          <li>Ongoing support and monitoring</li>
        </ul>
        <p><strong>3. Nutritional Supplementation (Initially):</strong></p>
        <ul>
          <li><strong>Correct deficiencies identified:</strong>
            <ul>
              <li>Iron (often IV if severe malabsorption)</li>
              <li>Folate and B12</li>
              <li>Calcium and vitamin D</li>
              <li>Other vitamins/minerals as needed</li>
            </ul>
          </li>
          <li>Most can discontinue supplements once mucosa heals</li>
        </ul>
        <p><strong>4. Monitoring and Follow-up:</strong></p>
        <ul>
          <li><strong>Regular follow-up essential:</strong>
            <ul>
              <li>Initially 3-6 monthly, then annually</li>
              <li>Dietitian review</li>
              <li>Symptom assessment</li>
              <li>Dietary adherence assessment</li>
              <li>Screen for complications</li>
            </ul>
          </li>
          <li><strong>Serological monitoring:</strong>
            <ul>
              <li>Repeat tTG-IgA at 6 months, then annually</li>
              <li>Should normalize on strict GFD</li>
              <li>Persistent elevation suggests ongoing gluten exposure or non-adherence</li>
            </ul>
          </li>
          <li><strong>Repeat biopsy:</strong>
            <ul>
              <li>Not routinely required if clinical and serological response adequate</li>
              <li>Consider if:
                <ul>
                  <li>Persistent symptoms despite GFD</li>
                  <li>Antibodies remain elevated</li>
                  <li>Concern for complications (e.g., refractory coeliac disease)</li>
                </ul>
              </li>
            </ul>
          </li>
          <li><strong>Nutritional monitoring:</strong>
            <ul>
              <li>Annual FBC, iron studies, B12, folate</li>
              <li>Calcium, vitamin D</li>
              <li>Liver function tests</li>
              <li>Thyroid function (increased risk of thyroid disease)</li>
            </ul>
          </li>
          <li><strong>Bone health:</strong>
            <ul>
              <li>DEXA scan at diagnosis if risk factors</li>
              <li>Repeat based on initial results and risk factors</li>
              <li>Ensure adequate calcium and vitamin D</li>
            </ul>
          </li>
        </ul>
        <p><strong>5. Vaccination:</strong></p>
        <ul>
          <li>Pneumococcal vaccination recommended (functional hyposplenism possible)</li>
        </ul>
        <p><strong>6. Patient Education and Support:</strong></p>
        <ul>
          <li>Join coeliac support groups</li>
          <li>Education about:
            <ul>
              <li>Lifelong nature of condition</li>
              <li>Importance of strict adherence</li>
              <li>Complications of non-adherence</li>
              <li>Practical aspects of maintaining GFD</li>
              <li>Dining out, travel considerations</li>
            </ul>
          </li>
          <li>Psychological support if needed (adjustment to diagnosis, dietary restrictions)</li>
        </ul>
        <p><strong>7. Family Screening:</strong></p>
        <ul>
          <li>Offer screening to first-degree relatives (10% risk)</li>
        </ul>
        <p><strong>Refractory Coeliac Disease:</strong></p>
        <ul>
          <li>Persistent symptoms and villous atrophy despite strict GFD for >12 months</li>
          <li>Rare (~1-2% of coeliac patients)</li>
          <li>Type 1: Normal intraepithelial lymphocytes</li>
          <li>Type 2: Abnormal (clonal) intraepithelial lymphocytes - higher risk of lymphoma</li>
          <li>Requires specialist management, may need immunosuppression</li>
        </ul>
        <p><strong>Complications of Untreated Coeliac Disease:</strong></p>
        <p><strong>Nutritional and Metabolic:</strong></p>
        <ul>
          <li><strong>Anaemia:</strong> Iron, folate, B12 deficiency</li>
          <li><strong>Osteoporosis/osteomalacia:</strong>
            <ul>
              <li>Calcium and vitamin D malabsorption</li>
              <li>Increased fracture risk</li>
              <li>May be irreversible if diagnosis delayed</li>
            </ul>
          </li>
          <li><strong>Vitamin and mineral deficiencies</strong></li>
          <li><strong>Malnutrition and weight loss</strong></li>
        </ul>
        <p><strong>Reproductive:</strong></p>
        <ul>
          <li>Infertility (male and female)</li>
          <li>Recurrent miscarriage</li>
          <li>Intrauterine growth restriction</li>
          <li>Preterm birth</li>
          <li>Low birth weight</li>
        </ul>
        <p><strong>Malignancy:</strong></p>
        <ul>
          <li><strong>Enteropathy-associated T-cell lymphoma (EATL):</strong>
            <ul>
              <li>Rare but serious complication</li>
              <li>Risk reduced by adherence to GFD</li>
              <li>Present with refractory symptoms, weight loss, abdominal pain</li>
              <li>Poor prognosis</li>
            </ul>
          </li>
          <li><strong>Small bowel adenocarcinoma:</strong> Slightly increased risk</li>
          <li><strong>Other malignancies:</strong> Small increased risk of oesophageal, oropharyngeal cancers</li>
          <li><strong>Non-Hodgkin lymphoma:</strong> Slightly increased risk</li>
          <li>Adherence to strict GFD reduces malignancy risk towards that of general population</li>
        </ul>
        <p><strong>Neurological:</strong></p>
        <ul>
          <li>Peripheral neuropathy</li>
          <li>Ataxia</li>
          <li>Epilepsy</li>
          <li>Cognitive impairment</li>
        </ul>
        <p><strong>Other Autoimmune Conditions:</strong></p>
        <ul>
          <li>Increased risk of other autoimmune diseases:
            <ul>
              <li>Type 1 diabetes</li>
              <li>Autoimmune thyroid disease</li>
              <li>Autoimmune hepatitis</li>
              <li>Primary biliary cholangitis</li>
              <li>Addison's disease</li>
            </ul>
          </li>
        </ul>
        <p><strong>Hyposplenism:</strong></p>
        <ul>
          <li>Functional hyposplenism can occur</li>
          <li>Increased risk of overwhelming bacterial infections</li>
          <li>Pneumococcal vaccination recommended</li>
        </ul>
        <p><strong>Quality of Life:</strong></p>
        <ul>
          <li>Chronic symptoms affecting daily functioning</li>
          <li>Fatigue</li>
          <li>Depression and anxiety</li>
          <li>Reduced quality of life</li>
        </ul>
        <p><strong>Prognosis:</strong></p>
        <ul>
          <li>Excellent prognosis with strict adherence to GFD</li>
          <li>Most symptoms resolve</li>
          <li>Nutritional status normalizes</li>
          <li>Risk of complications dramatically reduced</li>
          <li>Life expectancy normal with treatment</li>
          <li>Small percentage develop refractory disease despite GFD</li>
        </ul>
      </div>
    </div>

    <div class="question">
      <strong>5. What is non-coeliac gluten sensitivity (NCGS), and how does it differ from coeliac disease and wheat allergy?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p>This question explores the differential diagnosis of gluten-related disorders.</p>
        <p><strong>Non-Coeliac Gluten Sensitivity (NCGS):</strong></p>
        <ul>
          <li><strong>Definition:</strong>
            <ul>
              <li>Symptomatic condition triggered by gluten ingestion</li>
              <li>Occurs in individuals without coeliac disease or wheat allergy</li>
              <li>No specific biomarker - diagnosis of exclusion</li>
              <li>Prevalence uncertain, possibly 0.5-13% of population</li>
            </ul>
          </li>
          <li><strong>Pathophysiology:</strong>
            <ul>
              <li>Not fully understood</li>
              <li>May involve innate immune activation</li>
              <li>No autoimmune component</li>
              <li>No villous atrophy</li>
              <li>Debate whether gluten or other wheat components (FODMAPs, ATIs) responsible</li>
            </ul>
          </li>
          <li><strong>Clinical features:</strong>
            <ul>
              <li>GI symptoms: bloating, abdominal pain, diarrhoea/constipation</li>
              <li>Extra-intestinal: fatigue, headache, "brain fog", joint/muscle pain</li>
              <li>Symptoms develop hours to days after gluten ingestion</li>
              <li>Improve with gluten withdrawal</li>
            </ul>
          </li>
          <li><strong>Diagnosis:</strong>
            <ul>
              <li>Exclusion of coeliac disease (negative serology and/or biopsy)</li>
              <li>Exclusion of wheat allergy (negative IgE testing)</li>
              <li>Symptomatic response to gluten-free diet</li>
              <li>Symptom recurrence with gluten challenge</li>
              <li>Ideally confirmed with blinded placebo-controlled challenge</li>
            </ul>
          </li>
        </ul>
        <p><strong>Comparison of Gluten-Related Disorders:</strong></p>
        <table style="width:100%; border-collapse: collapse; margin-top: 10px;">
          <tr style="background-color: #f0f0f0;">
            <th style="border: 1px solid #ddd; padding: 8px; text-align: left;">Feature</th>
            <th style="border: 1px solid #ddd; padding: 8px; text-align: left;">Coeliac Disease</th>
            <th style="border: 1px solid #ddd; padding: 8px; text-align: left;">Wheat Allergy</th>
            <th style="border: 1px solid #ddd; padding: 8px; text-align: left;">NCGS</th>
          </tr>
          <tr>
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>Mechanism</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">Autoimmune (adaptive immunity)</td>
            <td style="border: 1px solid #ddd; padding: 8px;">IgE-mediated allergic reaction</td>
            <td style="border: 1px solid #ddd; padding: 8px;">Unclear, possibly innate immunity</td>
          </tr>
          <tr>
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>Genetics</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">HLA-DQ2/DQ8 required</td>
            <td style="border: 1px solid #ddd; padding: 8px;">No specific association</td>
            <td style="border: 1px solid #ddd; padding: 8px;">No HLA-DQ2/DQ8 association</td>
          </tr>
          <tr>
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>Antibodies</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">Anti-tTG, anti-EMA, anti-DGP</td>
            <td style="border: 1px solid #ddd; padding: 8px;">IgE to wheat proteins</td>
            <td style="border: 1px solid #ddd; padding: 8px;">May have AGA (non-specific)</td>
          </tr>
          <tr>
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>Intestinal damage</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">Villous atrophy</td>
            <td style="border: 1px solid #ddd; padding: 8px;">Normal or mild inflammation</td>
            <td style="border: 1px solid #ddd; padding: 8px;">Normal or minimal changes</td>
          </tr>
          <tr>
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>Onset of symptoms</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">Hours to days</td>
            <td style="border: 1px solid #ddd; padding: 8px;">Minutes to hours</td>
            <td style="border: 1px solid #ddd; padding: 8px;">Hours to days</td>
          </tr>
          <tr>
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>Symptoms</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">GI + systemic</td>
            <td style="border: 1px solid #ddd; padding: 8px;">GI, respiratory, skin, anaphylaxis</td>
            <td style="border: 1px solid #ddd; padding: 8px;">GI + systemic (no anaphylaxis)</td>
          </tr>
          <tr>
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>Complications</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">Malabsorption, osteoporosis, lymphoma</td>
            <td style="border: 1px solid #ddd; padding: 8px;">Anaphylaxis (potentially fatal)</td>
            <td style="border: 1px solid #ddd; padding: 8px;">No known long-term complications</td>
          </tr>
          <tr>
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>Treatment</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">Strict lifelong GFD essential</td>
            <td style="border: 1px solid #ddd; padding: 8px;">Strict wheat avoidance, may carry EpiPen</td>
            <td style="border: 1px solid #ddd; padding: 8px;">Gluten reduction/elimination (strict avoidance may not be necessary)</td>
          </tr>
          <tr>
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>Prognosis</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">Lifelong condition</td>
            <td style="border: 1px solid #ddd; padding: 8px;">May outgrow (especially children)</td>
            <td style="border: 1px solid #ddd; padding: 8px;">Variable, may improve over time</td>
          </tr>
          <tr>
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>Small amounts tolerated?</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">No (even trace amounts harmful)</td>
            <td style="border: 1px solid #ddd; padding: 8px;">No (risk of anaphylaxis)</td>
            <td style="border: 1px solid #ddd; padding: 8px;">Possibly (threshold varies)</td>
          </tr>
        </table>
        <p><strong>Clinical Significance:</strong></p>
        <ul>
          <li><strong>Coeliac disease must be excluded before diagnosing NCGS:</strong>
            <ul>
              <li>Serious long-term complications if coeliac disease missed</li>
              <li>Once on GFD, coeliac disease harder to diagnose (serology becomes negative)</li>
              <li>Would require prolonged gluten challenge to re-test</li>
            </ul>
          </li>
          <li><strong>Different management implications:</strong>
            <ul>
              <li>Coeliac: strict lifelong GFD mandatory, regular monitoring needed</li>
              <li>NCGS: symptom-guided, less strict, no monitoring required</li>
              <li>Wheat allergy: complete wheat avoidance, allergy management</li>
            </ul>
          </li>
          <li><strong>No need for family screening in NCGS (unlike coeliac disease)</strong></li>
        </ul>
        <p><strong>Diagnostic Approach to Patient with Suspected Gluten-Related Disorder:</strong></p>
        <ol>
          <li>Patient presents with symptoms possibly related to gluten</li>
          <li>While still on gluten-containing diet:
            <ul>
              <li>Test for coeliac disease: tTG-IgA + total IgA</li>
              <li>Consider wheat allergy testing (IgE) if rapid-onset symptoms</li>
            </ul>
          </li>
          <li>If coeliac serology positive → endoscopy + biopsy</li>
          <li>If coeliac disease confirmed → lifelong strict GFD, specialist follow-up</li>
          <li>If coeliac disease and wheat allergy excluded but symptoms persist:
            <ul>
              <li>Trial of gluten-free diet</li>
              <li>If symptoms improve → consider NCGS</li>
              <li>Ideally confirm with blinded gluten challenge</li>
            </ul>
          </li>
          <li>Consider other causes: IBS, FODMAP sensitivity, other food intolerances</li>
        </ol>
      </div>
    </div>

  
</div>

<!-- JavaScript -->  <script src="../js/firebase-config.js"></script>
  <script src="../js/auth.js"></script>
  <script src="../js/completion-tracker.js"></script>
  <script src="../js/flag-tracker.js"></script>
  <script src="../js/case-interactions.js"></script>

  <script>
    // Toggle case completion
    function toggleCaseCompletion() {
      if (window.completionTracker) {
        const caseId = window.completionTracker.getCurrentCaseId();
        if (caseId) {
          window.completionTracker.toggleCompletion(caseId);
        }
      }
    }// Toggle case flag
    function toggleCaseFlag() {
      console.log('toggleCaseFlag() function called');
      console.log('window.flagTracker exists:', !!window.flagTracker);

      if (!window.flagTracker) {
        console.error('window.flagTracker is not defined!');
        alert('Flag tracker not initialized. Please refresh the page.');
        return;
      }

      const caseId = window.flagTracker.getCurrentCaseId();
      console.log('Current case ID:', caseId);

      if (!caseId) {
        console.error('Could not get case ID');
        alert('Could not determine case ID');
        return;
      }

      console.log('Calling window.flagTracker.toggleCaseFlag with caseId:', caseId);
      window.flagTracker.toggleCaseFlag(caseId);
    }

    // Update case flag button state on page load
    document.addEventListener('DOMContentLoaded', () => {
      if (window.flagTracker) {
        setTimeout(() => {
          const caseId = window.flagTracker.getCurrentCaseId();
          if (caseId) {
            window.flagTracker.updateCaseFlagButton(caseId);
          }
        }, 100);
      }
    });
    }
  </script>

</body>
</html>
